| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,960 | 2,280 | 07:30 | |
| 2,060 | 2,080 | 07:30 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | 4DMEDICAL LIMITED: Results of AGM | 1 | ASX | ||
| Di | 4DMEDICAL LIMITED: Quarterly Activity Report and Appendix 4C | 2 | ASX | ||
| Di | 4DMEDICAL LIMITED: AGM Presentation and Chair's address | 1 | ASX | ||
| Fr | 4DMEDICAL LIMITED: Notice of 2026 Annual General Meeting - Clarification | 1 | ASX | ||
| 16.10. | 4DMEDICAL LIMITED: Application for quotation of securities - 4DX | 1 | ASX | ||
| 16.10. | 4DMEDICAL LIMITED: Addendum to 2026 Notice of Annual General Meeting | 1 | ASX | ||
| 07.10. | 5 australische Aktien, die kaum jemand auf dem Schirm hat - 3 davon zielen auf Märkte mit bis zu 120 Mrd. US-Dollar | Small- & Micro Cap Investment | |||
| 4DMEDICAL Aktie jetzt für 0€ handeln | |||||
| 02.10. | 4DMEDICAL LIMITED: Notification of cessation of securities - 4DX | 9 | ASX | ||
| 28.09. | 4DMEDICAL LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 25.09. | 4DMEDICAL LIMITED: Becoming a substantial holder | 1 | ASX | ||
| 24.09. | 4DMedical Ltd Full Year Sales Increase | 1 | RTTNews | ||
| 24.09. | 4DMEDICAL LIMITED: Notice of Annual General Meeting/Proxy Form | 1 | ASX | ||
| 24.09. | 4DMEDICAL LIMITED: Appendix 4G and Corporate Governance Statement | 1 | ASX | ||
| 24.09. | 4DMEDICAL LIMITED: FY26 Annual Report | 3 | ASX | ||
| 23.09. | 4DMEDICAL LIMITED: Initial Director's Interest Notice - CJ | - | ASX | ||
| 23.09. | 4DMEDICAL LIMITED: Board transition and key personnel appointments | - | ASX | ||
| 23.09. | 4DMEDICAL LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 18.09. | 4DMEDICAL LIMITED: Application for quotation of securities - 4DX | - | ASX | ||
| 18.09. | 4DMedical shares are rocketing 11% today. Is a short squeeze starting? | 2 | The Motley Fool Australia | ||
| 17.09. | 4DMedical präsentiert Wachstumsstrategie für Lungenbildgebung auf Investorenforum | 2 | Investing.com Deutsch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 6,756 | +0,96 % | Teladoc Q3 2026 slides: margins expand as BetterHelp shifts to insurance | ||
| SERNOVA BIOTHERAPEUTICS | 0,075 | +8,12 % | Sernova Biotherapeutics mit EILMELDUNG: Könnte die Aktie nach 33,3 % Plus jetzt komplett durchstarten? - Handeln Sie, bevor es zu spät ist! | ||
| CERENOME | 1,394 | +6,74 % | Cerenome, Inc.: Cerenome to Present Interim Clinical Update on the ReSPECT-LM Trial of Multiple REYOBIQ' Doses in Leptomeningeal Metastases | ||
| ATOSSA THERAPEUTICS | 2,120 | 0,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 17,200 | -2,82 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,440 | -0,29 % | Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India | .release-content span.prnews_span{font-size:8pt;font-family:"Arial";color:black}.release-content a.prnews_a{color:blue}.release-content li.prnews_li{font-size:8pt;font-family:"Arial";color:black}.release-content... ► Artikel lesen | |
| QUIDELORTHO | 12,250 | -2,43 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,270 | 0,00 % | Oppenheimer reiterates Veru stock rating ahead of obesity trial data | ||
| LIFEWARD | 6,000 | +1,69 % | Lifeward Ltd. - 8-K, Current Report | ||
| CLOVER HEALTH INVESTMENTS | 4,270 | -0,23 % | Clover Health im Aufwind: Needham startet Coverage mit "Buy" und Kursziel von 6 Dollar | ||
| SENSEONICS | 8,050 | -3,59 % | Senseonics Holdings, Inc.: Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World's First CGM System with No On-body Component | ||
| NANO-X IMAGING | 0,321 | -0,06 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| TEMPEST THERAPEUTICS | 0,519 | -1,29 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| IMUNON | 0,805 | +7,33 % | Imunon, Inc. - S-1, General form for registration of securities |